I usually don't give stock tips, but just this once I'll make an exception. My money is on Britain's GW Pharmaceuticals, whose new marajuana-based drug for obesity (!) is slated to begin clinical trials this week.CNN:
Cannabis is commonly associated with stimulating hunger. GW Pharma, however, says it has derived a treatment from cannabis itself that could help suppress hunger."The cannabis (pot) plant has 70 different cannabinoids in it, and each has a different affect on the body. (Amen!) Some can stimulate your appetite, and some in the same plant can suppress your appetite. It is amazing both scientifically and commercially." GW Managing Director Justin Gover told Reuters.
GW Pharma (whose marijuana plants are grown indoors in a secret location in Southern England) previously developed another pot-based drug: an under-the-tongue spray that diminishes some effects of multiple sclerosis.
Thank God this is only intended to be a stock tip (and not a social commentary) so I can spare you my opinions about medical marijuana or the so called "war on drugs."
So what are you waiting for? Call your broker!
(Next Tuesday, we'll return to the usual format discussing beauty tips and celebrity gossip.)
No comments:
Post a Comment